JP2018532384A5 - - Google Patents

Download PDF

Info

Publication number
JP2018532384A5
JP2018532384A5 JP2018511420A JP2018511420A JP2018532384A5 JP 2018532384 A5 JP2018532384 A5 JP 2018532384A5 JP 2018511420 A JP2018511420 A JP 2018511420A JP 2018511420 A JP2018511420 A JP 2018511420A JP 2018532384 A5 JP2018532384 A5 JP 2018532384A5
Authority
JP
Japan
Prior art keywords
lsp
compound
assay system
enzyme
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018511420A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018532384A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/049869 external-priority patent/WO2017040762A2/en
Publication of JP2018532384A publication Critical patent/JP2018532384A/ja
Publication of JP2018532384A5 publication Critical patent/JP2018532384A5/ja
Pending legal-status Critical Current

Links

JP2018511420A 2015-09-04 2016-09-01 新規な抗生物質を同定するための方法および関連組成物 Pending JP2018532384A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562214695P 2015-09-04 2015-09-04
US62/214,695 2015-09-04
PCT/US2016/049869 WO2017040762A2 (en) 2015-09-04 2016-09-01 Methods for identifying novel antibiotics and related compositions

Publications (2)

Publication Number Publication Date
JP2018532384A JP2018532384A (ja) 2018-11-08
JP2018532384A5 true JP2018532384A5 (https=) 2019-10-03

Family

ID=58189060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018511420A Pending JP2018532384A (ja) 2015-09-04 2016-09-01 新規な抗生物質を同定するための方法および関連組成物

Country Status (6)

Country Link
US (1) US20190144912A1 (https=)
EP (1) EP3344043A4 (https=)
JP (1) JP2018532384A (https=)
CN (1) CN108135181A (https=)
CA (1) CA2997530A1 (https=)
WO (1) WO2017040762A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200181101A1 (en) * 2017-07-05 2020-06-11 The Scripps Research Institute Benzamide inhibitors of bacterial lipoprotein signal peptidase
EP3587382A1 (en) * 2018-06-28 2020-01-01 Rheinische Friedrich-Wilhelms-Universität Bonn Click-mass spectrometry of alkyne-labeled compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62236494A (ja) * 1986-04-08 1987-10-16 Sumitomo Chem Co Ltd シグナルペプチダ−ゼに対するモノクロ−ナル抗体、およびそれを産生するハイブリド−マ
CA2032914A1 (en) * 1989-12-26 1991-06-27 Peter C.K. Lau Use of bacterial lipoprotein amino terminus in fusion plasmids for in vivo expression of lipid modified polypeptides
US7888005B2 (en) * 2003-02-12 2011-02-15 The Curators Of The University Of Missouri Inhibitors of macromolecular activity
FR2890446B1 (fr) * 2005-09-05 2008-04-18 Cis Bio Internat Sa Methode de detection d'interaction intracellulaire entre bio-molecules
BRPI0818162B1 (pt) * 2007-10-10 2023-11-07 Givaudan Sa Método para identificar modulador da formação de mau cheiro no corpo, kit, método para inibir peptidase em sua capacidade de clivar seu substrato e método para formar peptidase
GB0724051D0 (en) * 2007-12-08 2008-01-16 Medical Res Council Mutant proteins and methods for producing them
US20130012687A1 (en) * 2009-09-21 2013-01-10 The Board Of Trustees Of The Leland Stanford Junior University Inducible self-cleaving protease tag and method of purifying recombinant proteins using the same
CN103502466A (zh) * 2010-09-07 2014-01-08 斯隆-凯特林纪念癌症中心 用于γ-分泌酶测定的方法和组合物
EP2612916A1 (en) * 2012-01-09 2013-07-10 Universität Zürich Cellular high throughput encapsulation for screening or selection
JP6327662B2 (ja) * 2012-09-26 2018-05-23 学校法人藤田学園 細胞表面タンパクを抗原とする抗体を測定する方法
GB201222833D0 (en) * 2012-12-18 2013-01-30 Isis Innovation Detection of membrane proteins
US20140287447A1 (en) * 2013-03-14 2014-09-25 Ronald R. Fiscus Ultrasensitive methodology for quantifying the kinase catalytic activity of any protein kinase in biological/clinical samples or recombinant/purified proteins using near-infrared-fluorescence (NIRF)-labeled, kinase-selective peptide substrates and a combination of kinase-selective inhibitors to define individual kinase activity

Similar Documents

Publication Publication Date Title
Kitamura et al. Expedited approach toward the rational design of noncovalent SARS-CoV-2 main protease inhibitors
Mensa et al. Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16
Ogilvie et al. Peptidomimetic inhibitors of the human cytomegalovirus protease
Bogyo et al. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs
Osman et al. Why all the fury over furin?
Weigel et al. Phenylalanine and phenylglycine analogues as arginine mimetics in dengue protease inhibitors
Loregian et al. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase
US20240083885A1 (en) Compositions and methods for inhibiting m pro protease activity and for preventing and treating sars-cov-2 infection
US9187524B2 (en) Broad spectrum antibiotic arylomycin analogs
MD Bastos et al. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis
US20160297851A1 (en) Broad spectrum antibiotic arylomycin analogs
JP2010506166A (ja) デング熱の診断及び治療
Breuning et al. Michael acceptor based antiplasmodial and antitrypanosomal cysteine protease inhibitors with unusual amino acids
WO2005043118A2 (en) Drug discovery method
Weisshaar et al. Identification and characterization of influenza virus entry inhibitors through dual myxovirus high-throughput screening
Xu et al. A commensal dipeptidyl aminopeptidase with specificity for N-terminal glycine degrades human-produced antimicrobial peptides in vitro
Ridgway et al. Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies
JP2018532384A5 (https=)
Lange et al. Fragment‐Based Design, Synthesis, and Characterization of Aminoisoindole‐Derived Furin Inhibitors
US20240401101A1 (en) A live cell assay to determine permeability of test molecules to and/or within the peptidoglycan scaffold of bacteria cells
EP2365091A1 (en) Method of screening for HtrA protease inhibitors useful for prophylaxis and therapy of a bacterial infection
EP3097124B1 (en) Means and methods for detecting activated malt1
Brennan et al. Elucidating the Role of the Competence Regulon Quorum Sensing Circuitry in Streptococcus cristatus
Heal et al. Application of activity-based protein profiling to the study of microbial pathogenesis
JP2008538178A5 (https=)